ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.480
-0.500 (-16.78%)
At close: Sep 12, 2025, 4:00 PM EDT
2.510
+0.030 (1.21%)
After-hours: Sep 12, 2025, 7:59 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $729.82 million as of September 12, 2025. Its market cap has increased by 161.98% in one year.
Market Cap
729.82M
Enterprise Value
439.51M
1-Year Change
161.98%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $729.82M, an increase of 1,343.76%. That is a compound annual growth rate of 88.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 334.78M | 54.80% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |